NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.64
-0.91 (-2.98%)
At close: Jul 24, 2026, 4:00 PM EDT
30.09
+0.45 (1.52%)
After-hours: Jul 24, 2026, 7:58 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.47 billion as of July 24, 2026. Its market cap has increased by 28.70% in one year.
Market Cap
3.47B
Enterprise Value
2.76B
1-Year Change
28.70%
Ranking
Category
Stock Price
$29.64
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.47B, an increase of 2,143.48%. That is a compound annual growth rate of 76.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.47B | -12.89% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.11B |
| Tango Therapeutics | 3.97B |
| Dyne Therapeutics | 3.95B |
| Arcus Biosciences | 3.74B |
| Denali Therapeutics | 3.72B |
| Enliven Therapeutics | 3.69B |
| Structure Therapeutics | 3.61B |
| Alumis | 3.61B |